Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Counterpulsation Reduces Infarct Size Pre-PCI for AMI

Study:

A Multi-center, Randomized, Controlled Study of Mechanical Left Ventricular Unloading With Counterpulsation to Reduce Infarct Size Pre-PCI for Acute Myocardial Infarction - CRISP AMI

Rationale:

n/a

Purpose:

Subjects with anterior acute STEMI who receive an IABC before primary PCI will have decreased MI size.

Study Status: Completed

Recruiting:
n/a

Condition Intervention Phase
Acute Myocardial Infarction (AMI) Device: Counterpulsation with IAB Phase 4

Verified by Datascope Corp. June, 2011

Sponsored by: Datascope Corp.
Information provided by: Datascope Corp.
ClinicalTrials.gov identifier: NCT00833612

Study Type: Interventional

Study Design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Cleveland Clinic Florida
Weston, Florida 33331
United States

Magnus Ohman, MD., Principal Investigator

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site